project id: TCGA-ESCA; case submitter id: TCGA-L7-A6VZ; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.74; rna integrity number: 8.5; age at index: 62; days to birth: -22730; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 22730; ajcc pathologic m: MX; ajcc pathologic n: N3; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 315.0; icd 10 code: C15.4; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle third of esophagus; synchronous malignancy: No; tissue or organ of origin: Middle third of esophagus; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 135; days to sample procurement: 0; initial weight: 550.0; portion submitter id: TCGA-L7-A6VZ-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 7.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 93.0; percent tumor nuclei: 75.0;